Sucai Liu1, Kapil Sirohi1, Mukesh Verma1, Jerome McKay1, Lidia Michalec1, Anand Sripada1, Tomas Danhorn2, Donald Rollins3, James Good3, Magdalena M Gorska4, Richard J Martin3, Rafeul Alam5. 1. Division of Allergy and Immunology, Department of Medicine, Denver, Colo. 2. Center for Genes and Environment, National Jewish Health, Denver, Colo. 3. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Denver, Colo; School of Medicine, University of Colorado Denver, Denver, Colo. 4. Division of Allergy and Immunology, Department of Medicine, Denver, Colo; School of Medicine, University of Colorado Denver, Denver, Colo. 5. Division of Allergy and Immunology, Department of Medicine, Denver, Colo; School of Medicine, University of Colorado Denver, Denver, Colo. Electronic address: alamr@njhealth.org.
Abstract
BACKGROUND: Human type 2 innate lymphoid cells (ILC2s) are identified by coupled detection of CRTH2 and IL7Rα on lineage negative (Lin-) cells. Type 2 cytokine production by CRTH2-IL7Rα- innate lymphoid cells (ILCs) is unknown. OBJECTIVE: We sought to identify CRTH2-IL7Rα- type 2 cytokine-producing ILCs and their disease relevance. METHODS: We studied human blood and lung ILCs from asthmatic and control subjects by flow cytometry, ELISA, RNA sequencing, quantitative PCR, adoptive transfer to mice, and measurement of airway hyperreactivity by Flexivent. RESULTS: We found that IL-5 and IL-13 were expressed not only by CRTH2+ but also by CRTH2-IL7Rα+ and CRTH2-IL7Rα- (double-negative [DN]) human blood and lung cells. All 3 ILC populations expressed type 2 genes and induced airway hyperreactivity when adoptively transferred to mice. The frequency of type 2 cytokine-positive IL7Rα and DN ILCs were similar to that of CRTH2 ILCs in the blood and lung. Their frequency was higher in asthmatic patients than in disease controls. Transcriptomic analysis of CRTH2, IL7Rα, and DN ILCs confirmed the expression of mRNA for type 2 transcription factors in all 3 populations. Unexpectedly, the mRNA for GATA3 and IL-5 correlated better with mRNA for CD30, TNFR2, ICOS, CCR4, and CD200R1 than for CRTH2. By using a combination of these surface markers, especially CD30/TNFR2, we identified a previously unrecognized ILC2 population. CONCLUSIONS: The commonly used surface markers for human ILC2s leave a majority of type 2 cytokine-producing ILC2s unaccounted for. We identified top GATA3-correlated cell surface-expressed genes in human ILCs by RNA sequencing. These new surface markers, such as CD30 and TNFR2, identified a previously unrecognized human ILC2 population. This ILC2 population is likely to contribute to asthma.
BACKGROUND:Human type 2 innate lymphoid cells (ILC2s) are identified by coupled detection of CRTH2 and IL7Rα on lineage negative (Lin-) cells. Type 2 cytokine production by CRTH2-IL7Rα- innate lymphoid cells (ILCs) is unknown. OBJECTIVE: We sought to identify CRTH2-IL7Rα- type 2 cytokine-producing ILCs and their disease relevance. METHODS: We studied human blood and lung ILCs from asthmatic and control subjects by flow cytometry, ELISA, RNA sequencing, quantitative PCR, adoptive transfer to mice, and measurement of airway hyperreactivity by Flexivent. RESULTS: We found that IL-5 and IL-13 were expressed not only by CRTH2+ but also by CRTH2-IL7Rα+ and CRTH2-IL7Rα- (double-negative [DN]) human blood and lung cells. All 3 ILC populations expressed type 2 genes and induced airway hyperreactivity when adoptively transferred to mice. The frequency of type 2 cytokine-positive IL7Rα and DN ILCs were similar to that of CRTH2 ILCs in the blood and lung. Their frequency was higher in asthmatic patients than in disease controls. Transcriptomic analysis of CRTH2, IL7Rα, and DN ILCs confirmed the expression of mRNA for type 2 transcription factors in all 3 populations. Unexpectedly, the mRNA for GATA3 and IL-5 correlated better with mRNA for CD30, TNFR2, ICOS, CCR4, and CD200R1 than for CRTH2. By using a combination of these surface markers, especially CD30/TNFR2, we identified a previously unrecognized ILC2 population. CONCLUSIONS: The commonly used surface markers for human ILC2s leave a majority of type 2 cytokine-producing ILC2s unaccounted for. We identified top GATA3-correlated cell surface-expressed genes in human ILCs by RNA sequencing. These new surface markers, such as CD30 and TNFR2, identified a previously unrecognized human ILC2 population. This ILC2 population is likely to contribute to asthma.
Authors: Jenny M Mjösberg; Sara Trifari; Natasha K Crellin; Charlotte P Peters; Cornelis M van Drunen; Berber Piet; Wytske J Fokkens; Tom Cupedo; Hergen Spits Journal: Nat Immunol Date: 2011-09-11 Impact factor: 25.606
Authors: J-P Choi; Y-M Kim; H-I Choi; S-J Choi; H T Park; W-H Lee; Y S Gho; Y-K Jee; S G Jeon; Y-K Kim Journal: Allergy Date: 2013-11-06 Impact factor: 13.146
Authors: Yoichiro Ohne; Jonathan S Silver; LuAnn Thompson-Snipes; Magalie A Collet; Jean Philippe Blanck; Brandi L Cantarel; Alan M Copenhaver; Alison A Humbles; Yong-Jun Liu Journal: Nat Immunol Date: 2016-04-25 Impact factor: 25.606
Authors: David J Jackson; Heidi Makrinioti; Batika M J Rana; Betty W H Shamji; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Aurica G Telcian; Alexandra Nikonova; Jie Zhu; Julia Aniscenko; Leila Gogsadze; Eteri Bakhsoliani; Stephanie Traub; Jaideep Dhariwal; James Porter; Duncan Hunt; Toby Hunt; Trevor Hunt; Luminita A Stanciu; Musa Khaitov; Nathan W Bartlett; Michael R Edwards; Onn Min Kon; Patrick Mallia; Nikolaos G Papadopoulos; Cezmi A Akdis; John Westwick; Matthew J Edwards; David J Cousins; Ross P Walton; Sebastian L Johnston Journal: Am J Respir Crit Care Med Date: 2014-12-15 Impact factor: 21.405
Authors: Yong Yu; Jason C H Tsang; Cui Wang; Simon Clare; Juexuan Wang; Xi Chen; Cordelia Brandt; Leanne Kane; Lia S Campos; Liming Lu; Gabrielle T Belz; Andrew N J McKenzie; Sarah A Teichmann; Gordon Dougan; Pentao Liu Journal: Nature Date: 2016-09-29 Impact factor: 49.962
Authors: Cyril Seillet; Lucille C Rankin; Joanna R Groom; Lisa A Mielke; Julie Tellier; Michael Chopin; Nicholas D Huntington; Gabrielle T Belz; Sebastian Carotta Journal: J Exp Med Date: 2014-08-04 Impact factor: 14.307
Authors: Ai Ing Lim; Silvia Menegatti; Jacinta Bustamante; Lionel Le Bourhis; Matthieu Allez; Lars Rogge; Jean-Laurent Casanova; Hans Yssel; James P Di Santo Journal: J Exp Med Date: 2016-03-14 Impact factor: 14.307
Authors: Luca Mazzurana; Paulo Czarnewski; Viktor Jonsson; Leif Wigge; Markus Ringnér; Teresa C Williams; Avinash Ravindran; Åsa K Björklund; Jesper Säfholm; Gunnar Nilsson; Sven-Erik Dahlén; Ann-Charlotte Orre; Mamdoh Al-Ameri; Charlotte Höög; Charlotte Hedin; Sylwester Szczegielniak; Sven Almer; Jenny Mjösberg Journal: Cell Res Date: 2021-01-08 Impact factor: 46.297